Top Markets
Coin of the day
LungLife AI, Inc. LungLife AI, Inc.

LungLife AI, Inc.

LLAI
Rang in aandelen #41525
LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating... LungLife AI, Inc. is a clinical diagnostics enterprise focused on creating AI-powered solutions for detecting lung cancer. The company is actively developing LungLB, an advanced blood-based test that harnesses artificial intelligence and machine learning. LungLB is designed to precisely identify and quantify circulating tumor cells (CTCs), ultimately aiming to minimize manual intervention and elevate diagnostic performance. The organization, which was previously known as Cynvenio Biosystems, Inc., adopted the LungLife AI, Inc. moniker in May of 2019. Its operations are based in Thousand Oaks, California.
Aandeelprijs
$0.05646911
Laatst gesynchroniseerd: 2025-05-28
Marktkapitalisatie
$17.31K
Verandering (1 dag)
-1.67%
Verandering (1 jaar)
0.00%
Land
US
Handel LungLife AI, Inc. (LLAI)

Categorie

Dividendrendementgeschiedenis voor LungLife AI, Inc. (LLAI)
Het dividendrendement (TTM) van LungLife AI, Inc. (aandelsymbool: LLAI) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van LungLife AI, Inc. (LLAI) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten